

Ixico
IXI:LNLondon Stock Exchange
Overview
Company Profile
Since 2004, we have been dedicated to delivering insights in neuroscience. Our mission is to transform the advancement of new therapies for neurological diseases through the application of medical image analysis, bringing safe and effective treatment to patients sooner. We are committed to advancing imaging biomarkers in CNS therapeutic areas such as Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.
Chart Rundown: November 036 days ago
Chart Rundown: November 2nd1 week ago
Q&A with IXICO CEO Bram Goorden and CFO Grant NashDec 12, 2025
The Exchange with Ken Wotton of Gresham HouseNov 18, 2025
Q&A with IXICO CEO Bram GoordenJul 17, 2025
Q&A with IXICO CEO Bram GoordenJul 17, 2025
Q&A with IXICO CEO Bram Goorden and CFO Grant NashMay 20, 2025Classification
SectorHealthcare
ExchangeLondon Stock Exchange
IndustryBiotechnology & Life Sciences
